M&A
confidence high
sentiment positive
materiality 0.85
Core Scientific investor presentation shows ~71% premium in CoreWeave merger; vote Oct 30
Core Scientific, Inc./tx
- Exchange ratio of 0.1235 CoreWeave shares per CORZ share, a ~71% premium to unaffected 10-day VWAP.
- Core Scientific stockholders will own ~8.9% of combined company; Board unanimously recommends FOR.
- Merger de-risks ~$7.3B financing need and is expected to generate $500M+ annual run-rate cost savings by 2027E.
- CoreWeave recently announced AI infrastructure deals with OpenAI (up to $6.5B) and Meta ($14.2B).